HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

2-(8-hydroxy-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-3-yl)-5-(hydroxymethyl)oxolane-3,4-diol

HCID 320
NotesReactions
Basic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
11033-22-0
Standard SMILES
OCC1OC(n2cnc3c2NC=NCC3O)C(O)C1O
InChIKey
YOOVTUPUBVHMPG-UHFFFAOYSA-N
Molecular formula
C11H16N4O5
Average molar mass
284.27 g/mol
Monoisotopic mass
284.11206962

Names & identifiers

Preferred name
2-(8-hydroxy-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-3-yl)-5-(hydroxymethyl)oxolane-3,4-diol
IUPAC
2-(8-hydroxy-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-3-yl)-5-(hydroxymethyl)oxolane-3,4-diol
English name
coformycin
Molecular formula
C11H16N4O5
Molecular weight
284.27

Names & synonyms

3-pentofuranosyl-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol2-(8-hydroxy-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-3-yl)-5-(hydroxymethyl)oxolane-3,4-diolNSC 277817NSC277817SCHEMBL14031897DTXSID50911591NCI60_002261coformycin5-d)(1,3)diazepin-8-ol,3,4,7,8-tetrahydro-3-beta-d-ribofuranosyl-imidazo(((8R)-3-β-D-Ribofuranosyl-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol(8R)-3,4,7,8-Tetrahydro-3-β-D-ribofuranosylimidazo[4,5-d][1,3]diazepin-8-ol(r)-3,4,7,8-tetrahydro-3-beta-d-ribofuranosylimidazo(4,5-d)(1,3)diazepin-8-o
Show more names
Imidazo[4,5-d][1,3]diazepin-8-ol, 3,4,7,8-tetrahydro-3-β-D-ribofuranosyl-, (8R)-

Database identifiers

CAS
11033-22-0
PubChem CID
320
DTXSID
DTXSID50911591

Properties

Computed structural properties

XLogP
-3.1
Topological polar surface area
132 Ų
Hydrogen bond donors
5
Hydrogen bond acceptors
7
Rotatable bonds
2
Heavy atoms
20
Formal charge
0
Complexity
384

Physicochemical properties

Melting point
182 · 182-184 °C
Boiling point
692.67 · 692.670±65.00 °C(Press: 760.00 Torr)(predicted)
Density
1.964 · 1.964±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
pka
12.826 · 12.826±0.20(predicted)
FDA UNII
49510 ZL0H · E49510ZL0H

Chemistry & industry

Applications · 1 item

DescriptionCoformycin is isolated from Nocardia interforma along with formycin. Coformycin shows a synergistic effect with formycin on Yoshida rat sarcoma cells because of its strong inhibition of adenosine deaminase, which inactivates formycin. Coformycin, having a characteristic seven-membered ring base moiety, is thought to be a typical example of a “transition-state analog” in the adenosine deaminase reaction. 2_x0002_-Deoxycoformycin (19b) has also been isolated also .

Suppliers5 total

成都诺维生物科技有限公司028-81458053 · [email protected] [email protected]
浙江珲达生物科技有限公司0571-89903022 18679456698 · [email protected]
南京克罗托鲁宁医药科技有限公司13382066392
BOC Sciences+1-631-485-4226 · [email protected]
TargetMol中国(陶术生物)15002134094 · [email protected]

Additional notes

DefinitionChEBI: An N-glycosyl in which (8R)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol is attached to ribofuranose via a beta-N3-glycosidic bond. compound The parent of the class of coformycins.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes